Furthermore, to determine whether AKT/NF-κB signaling pathway is responsible for iCAFs’ effect on cell migration and invasion, lung cancer cells were pretreated with either AKT inhibitor perifosine or NF-κB inhibitor JSH23 and then cultured in iCAFs-CM. This evidence concerns the gene AKT1 and lung carcinoma.